STORM Therapeutics Pioneering New RNA Pathways to Novel Therapies

“New technologies like RNA inhibitors that alter the genetic drivers of a disease, have the potential to transform medicine…”

Giulio Cerroni, CEO and Grant Nash CFO of IXICO (IXI)

Listen to Ixico’s interview on Vox Market’s daily podcast with Justin Waite. Forward to 23:00 minutes to hear them discuss their growth…

Artios Pharma CEO, Niall Martin is on a mission to put DNA repair on the map

Niall Martin is on a mission to put DNA repair on the map. He has already gone pretty far along the way to doing this, as the leader of the team that developed the blockbuster cancer drug Lynparza. He is now seeking to repeat this early success at Artios, where he is CEO. Martin talked […]

Verona Pharma Hosts Investor and Analyst R&D Forum 2019

Click this link to register and listen to the insightful podcast from Verona Pharma’s Investor and Analyst R&D Day forum 2019